IMPACT OF PROCEDURE VOLUME ON 30-DAY ALL-CAUSE READMISSIONS IN LAPAROSCOPIC AND ROBOTIC BARIATRIC SURGERY
Author(s)
Amos T1, Roy S2, Nagle D3, Ditto R4, Jain S5, Johnston S6
1Johnson & Johnson, Philadelphia , PA, USA, 2Ethicon Inc, Somerville, NJ, USA, 3Ethicon, Johnson and Johnson, Blue Ash, OH, USA, 4Ethicon Inc, Cincinnati, OH, USA, 5MuSigma, New Brunswick, NJ, USA, 6Johnson & Johnson, Annapolis, MD, USA
OBJECTIVES: To examine the impact of procedure volume on 30-day all-cause readmissions among patients undergoing laparoscopic or robotic bariatric surgery. METHODS: We extracted hospital discharge records from the Premier Healthcare Database for patients aged≥18 undergoing elective laparoscopic or robotic bariatric surgery (Roux-en-Y gastric bypass, sleeve gastrectomy) between 1-1-2015 and 12-31-2017 (first admission=index). For each patient, we used the month of index and 12 months prior to measure their hospital’s annual procedure volume of the specific procedure/approach that they underwent (Roux-en-Y/laparoscopic, Roux-en-Y/robotic, sleeve/laparoscopic, sleeve/robotic); we then used multivariable generalized estimating equations to quantify the association between the annual procedure volume (categorized in quartiles [Q1-Q4] from low-to-high volume) and 30-day all-cause readmission to the same hospital in which the bariatric surgery was performed, accounting for hospital-level clustering and adjusting for patients’ demographics, body mass index, comorbidities, and provider/hospital characteristics. RESULTS: The study included 30,301 Roux-en-Y/laparoscopic, 2,751 Roux-en-Y/robotic, 66,788 sleeve/laparoscopic, and 6,227 sleeve/robotic patients from 294 hospitals. In analyses of the laparoscopic approach, higher annual procedure volume was significantly associated with lower adjusted risk of 30-day all-cause readmission (Roux-en-Y/laparoscopic: Q1=6.5%, Q2=5.9%, Q3=4.8%, Q4=4.6%, P=0.002; sleeve/laparoscopic: Q1=3.3%, Q2=2.8%, Q3=2.9%, Q4=2.3%, P=0.006). In contrast, for the robotic approach, procedure volume was not significantly associated with adjusted risk of 30-day all-cause readmissions (Roux-en-Y/robotic: Q1=7.1 %, Q2=7.2%, Q3=7.0%, Q4=5.6%, P=0.836; sleeve/robotic: Q1=2.8%, Q2=2.5%, Q3=2.9%, Q4=3.9%, P=0.335). CONCLUSIONS: Among patients undergoing elective bariatric surgery, higher hospital procedure volume was significantly associated with lower adjusted risks of 30-day all-cause readmission for laparoscopic procedures but not robotic procedures. The robotic approach is a relatively new and less common technique in bariatric surgery; readmission data may reflect the fact that robotics is in early experience with hospitals and surgeons still advancing on their learning curves. More research is needed to understand the hospital and surgeon-specific factors which influence outcomes in robotic bariatric surgery.
Conference/Value in Health Info
2019-05, ISPOR 2019, New Orleans, LA, USA
Value in Health, Volume 22, Issue S1 (2019 May)
Code
PSU6
Topic
Clinical Outcomes
Topic Subcategory
Performance-based Outcomes
Disease
No Specific Disease, Surgery